In addition, RBM47 expression was notably higher in isocitrate dehydrogenase (IDH)-wild-type glioma samples, those without 1p/19q co-deletion, and those devoid of methylguanine-DNA methyltransferase promoter methylation (Fig. 2B–D). This evidence concerns the gene MGMT and central nervous system cancer.